Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach

Written By Krista Verlis

Pathirana, T., Hayen, A., Doust, J., Glasziou, P., & Bell, K. (2019). Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach. BMJ open, 9(3), e022457. https://doi.org/10.1136/bmjopen-2018-022457

https://bmjopen.bmj.com/content/9/3/e022457#new_tab

Krista Verlis
Previous

Measuring Hospital-Acquired Complications Associated With Low-Value Care
Next

Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment